Content Navigation
( All
None )
| Target and Pathway |
Top |
| Target(s) |
Prostaglandin D2 receptor 2 (PTGDR2) |
Target Info
|
Antagonist |
[2] |
| References |
Top |
| REF 1 |
ClinicalTrials.gov (NCT03226392) Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma. U.S. National Institutes of Health.
|
| REF 2 |
Fevipiprant in the treatment of asthma. Expert Opin Investig Drugs. 2018 Feb;27(2):199-207.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.
